BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwach V, Slaats RH, Passier R. Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity. Front Cardiovasc Med 2020;7:50. [PMID: 32322588 DOI: 10.3389/fcvm.2020.00050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiang Y, Liu H, Yang W, Xu Z, Wu Y, Tang Z, Zhu Z, Zeng Z, Wang D, Wang T, Hu N, Zhang D. A biosensing system employing nanowell microelectrode arrays to record the intracellular potential of a single cardiomyocyte. Microsyst Nanoeng 2022;8:70. [PMID: 35774495 DOI: 10.1038/s41378-022-00408-9] [Reference Citation Analysis]
2 Wang H, Wu Y, Zou Q, Yang W, Xu Z, Dong H, Zhu Z, Wang D, Wang T, Hu N, Zhang D. A biosensing system using a multiparameter nonlinear dynamic analysis of cardiomyocyte beating for drug-induced arrhythmia recognition. Microsyst Nanoeng 2022;8:49. [PMID: 35547605 DOI: 10.1038/s41378-022-00383-1] [Reference Citation Analysis]
3 Narkar A, Willard JM, Blinova K. Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs). Int J Mol Sci 2022;23:3199. [PMID: 35328619 DOI: 10.3390/ijms23063199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sheibani M, Azizi Y, Shayan M, Nezamoleslami S, Eslami F, Farjoo MH, Dehpour AR. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches. Cardiovasc Toxicol. [DOI: 10.1007/s12012-022-09721-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Prathumsap N, Ongnok B, Khuanjing T, Arinno A, Maneechote C, Apaijai N, Chunchai T, Arunsak B, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N. Acetylcholine receptor agonists provide cardioprotection in doxorubicin-induced cardiotoxicity via modulating muscarinic M2 and α7 nicotinic receptor expression. Transl Res 2021:S1931-5244(21)00288-7. [PMID: 34920165 DOI: 10.1016/j.trsl.2021.12.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ohya T, Ohtomo H, Kikuchi T, Sasaki D, Kawamura Y, Matsuura K, Shimizu T, Fukuda K, Someya T, Umezu S. Simultaneous measurement of contractile force and field potential of dynamically beating human iPS cell-derived cardiac cell sheet-tissue with flexible electronics. Lab Chip 2021;21:3899-909. [PMID: 34636821 DOI: 10.1039/d1lc00411e] [Reference Citation Analysis]
7 Kulkeaw K, Pengsart W. Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases. Micromachines (Basel) 2021;12:842. [PMID: 34357252 DOI: 10.3390/mi12070842] [Reference Citation Analysis]
8 Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S. Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies. Front Cardiovasc Med 2021;8:690533. [PMID: 34277738 DOI: 10.3389/fcvm.2021.690533] [Reference Citation Analysis]
9 Perry TR, Roberts ML, Sunkara B, Maddula R, McLeish T, Gomez J, Lucas J, Rayan D, Patel S, Liang M, Bosnjak ZJ, Brown SA. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention. Curr Oncol Rep 2021;23:77. [PMID: 33937943 DOI: 10.1007/s11912-021-01066-2] [Reference Citation Analysis]
10 Smith AJ. Effects of Cardiotoxins on Cardiac Stem and Progenitor Cell Populations. Front Cardiovasc Med 2021;8:624028. [PMID: 33987210 DOI: 10.3389/fcvm.2021.624028] [Reference Citation Analysis]
11 Thomas D, Shenoy S, Sayed N. Building Multi-Dimensional Induced Pluripotent Stem Cells-Based Model Platforms to Assess Cardiotoxicity in Cancer Therapies. Front Pharmacol 2021;12:607364. [PMID: 33679396 DOI: 10.3389/fphar.2021.607364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sabbatino F, Conti V, Liguori L, Polcaro G, Corbi G, Manzo V, Tortora V, Carlomagno C, Vecchione C, Filippelli A, Pepe S. Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients. Life (Basel) 2021;11:105. [PMID: 33573162 DOI: 10.3390/life11020105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Fritsche E, Haarmann-Stemmann T, Kapr J, Galanjuk S, Hartmann J, Mertens PR, Kämpfer AAM, Schins RPF, Tigges J, Koch K. Stem Cells for Next Level Toxicity Testing in the 21st Century. Small 2021;17:e2006252. [PMID: 33354870 DOI: 10.1002/smll.202006252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hung YC, Wang PW, Lin TY, Yang PM, You JS, Pan TL. Functional Redox Proteomics Reveal That Salvia miltiorrhiza Aqueous Extract Alleviates Adriamycin-Induced Cardiomyopathy via Inhibiting ROS-Dependent Apoptosis. Oxid Med Cell Longev 2020;2020:5136934. [PMID: 32963697 DOI: 10.1155/2020/5136934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]